Nicholas Namias, M.D., M.B.A., Medical Director of the Ryder Trauma Center at the University of Miami/Jackson Memorial Hospital, was named the Chairman of the Florida Committee on Trauma (FCOT) by the American College of Surgeons.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has been recognized as a Cancer Center of Excellence by the state of Florida – one of just four cancer centers in the state, and the only one in South Florida, to have earned this first-ever distinction.
“I’m going to Atlanta!!!” It all poured out in a single high-pitched shriek of joy when fourth-year student Kristy Whyte opened the sealed white envelope to learn where she had been matched for her residency in emergency medicine.
A team of Miller School of Medicine researchers, collaborating with investigators at other institutions, has demonstrated that the cancer drug epothilone promotes regeneration and locomotor recovery following spinal cord injury in adult rats. The research was recently published in Science.
Miami CFAR, ISCI and Sylvester Researchers Receive Grant to Study Stem Cell Role in Kaposi’s Sarcoma 03.24.2015
An interdisciplinary team of Miller School of Medicine researchers has received a $1.8 million grant from the National Cancer Institute to study the role of stem cells in Kaposi’s sarcoma oncogenesis and therapy.
Two important genetic studies driven by the leader of the University of Miami Miller School of Medicine’s Sylvester Comprehensive Cancer Center provide new insights into an increasingly common bone marrow disorder known as myelodysplastic syndrome (MDS).
David Zambrana, D.N.P., M.B.A., the CEO of University of Miami Hospital, received the Hispanic Leadership Award in the health care category March 20 at the annual awards luncheon held by the South Florida Hispanic Chamber of Commerce. The awards luncheon is a signature event that recognizes individuals who demonstrate excellence in a variety of fields within the Hispanic market of South Florida.
More than 250 friends and supporters of Bascom Palmer Eye Institute attended a hard hat tour and reception at Bascom Palmer’s new eye center that is under construction on Tamiami Trail in Naples.
Joshua Hare, M.D., Director of the Interdisciplinary Stem Cell Institute at the Miller School of Medicine, has co-authored a new study in the Journal of Clinical Investigation demonstrating that mesenchymal stem cells (MSCs) create bone cells by triggering a biochemical switch that determines whether cells will become fat or bone.
Radiation Plus Immunotherapy Combination Improves Immune System Response to Metastatic Melanoma 03.24.2015
A triple attack of radiation plus two immunotherapies appears to improve the immune system response in patients with metastatic melanoma, according to a recent study from a multidisciplinary team of researchers, including the Miller School’s Hemant Ishwaran, Ph.D., professor of public health sciences.